BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37443404)

  • 1. Feasibility of Targeted Next-Generation DNA Sequencing for Expanding Population Newborn Screening.
    Shum BOV; Pretorius CJ; Sng LMF; Henner I; Barahona P; Basar E; McGill J; Wilgen U; Zournazi A; Downie L; Taylor N; Cheney L; Wu S; Twine NA; Bauer DC; Watts GF; Navilebasappa A; Kumar KR; Ungerer JPJ; Bennett G
    Clin Chem; 2023 Aug; 69(8):890-900. PubMed ID: 37443404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical feasibility of newborn screening for spinal muscular atrophy by next-generation DNA sequencing.
    Shum BOV; Henner I; Cairns A; Pretorius C; Wilgen U; Barahona P; Ungerer JPJ; Bennett G
    Front Genet; 2023; 14():1095600. PubMed ID: 36713073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates.
    Huang X; Wu D; Zhu L; Wang W; Yang R; Yang J; He Q; Zhu B; You Y; Xiao R; Zhao Z
    Orphanet J Rare Dis; 2022 Feb; 17(1):66. PubMed ID: 35193651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into National Laboratory Newborn Screening and Future Prospects.
    Mujamammi AH
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Integrated Newborn Screening Workflow Can Provide a Shortcut to Differential Diagnosis and Confirmation of Inherited Metabolic Diseases.
    Ko JM; Park KS; Kang Y; Nam SH; Kim Y; Park I; Chae HW; Lee SM; Lee KA; Kim JW
    Yonsei Med J; 2018 Jul; 59(5):652-661. PubMed ID: 29869463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Population-Based Genomic Study of Inherited Metabolic Diseases Detected Through Newborn Screening.
    Park KJ; Park S; Lee E; Park JH; Park JH; Park HD; Lee SY; Kim JW
    Ann Lab Med; 2016 Nov; 36(6):561-72. PubMed ID: 27578510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of archived residual newborn screening blood spots after whole genome amplification.
    Cantarel BL; Lei Y; Weaver D; Zhu H; Farrell A; Benstead-Hume G; Reese J; Finnell RH
    BMC Genomics; 2015 Aug; 16(1):602. PubMed ID: 26268606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Screening for Chromosome 15 Imprinting Disorders in 16 579 Newborns by Using a Novel Genomic Workflow.
    Godler DE; Ling L; Gamage D; Baker EK; Bui M; Field MJ; Rogers C; Butler MG; Murgia A; Leonardi E; Polli R; Schwartz CE; Skinner CD; Alliende AM; Santa Maria L; Pitt J; Greaves R; Francis D; Oertel R; Wang M; Simons C; Amor DJ
    JAMA Netw Open; 2022 Jan; 5(1):e2141911. PubMed ID: 34982160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates.
    Bodian DL; Klein E; Iyer RK; Wong WS; Kothiyal P; Stauffer D; Huddleston KC; Gaither AD; Remsburg I; Khromykh A; Baker RL; Maxwell GL; Vockley JG; Niederhuber JE; Solomon BD
    Genet Med; 2016 Mar; 18(3):221-30. PubMed ID: 26334177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening with targeted sequencing: a multicenter investigation and a pilot clinical study in China.
    Hao C; Guo R; Hu X; Qi Z; Guo Q; Liu X; Liu Y; Sun Y; Zhang X; Jin F; Wu X; Cai R; Zeng D; Hu X; Wang X; Ji X; Li W; Xing Q; Mu L; Jiang X; Yang X; Yang W; Zhang Y; Yin Q; Ni X; Li W
    J Genet Genomics; 2022 Jan; 49(1):13-19. PubMed ID: 34474183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a Targeted Next-Generation Sequencing Panel for Constitutional Newborn Screening in High-Risk Neonates.
    Lee H; Lim J; Shin JE; Eun HS; Park MS; Park KI; Namgung R; Lee JS
    Yonsei Med J; 2019 Nov; 60(11):1061-1066. PubMed ID: 31637888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Validation of a Custom NGS Panel Targeting a Set of Lysosomal Storage Diseases Candidate for NBS Applications.
    La Cognata V; Guarnaccia M; Morello G; Ruggieri M; Polizzi A; Cavallaro S
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Incidence of Severe Combined Immunodeficiency Disease in Saudi Arabia Detected Through Combined T Cell Receptor Excision Circle and Next Generation Sequencing of Newborn Dried Blood Spots.
    Al-Mousa H; Al-Dakheel G; Jabr A; Elbadaoui F; Abouelhoda M; Baig M; Monies D; Meyer B; Hawwari A; Dasouki M
    Front Immunol; 2018; 9():782. PubMed ID: 29713328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing as a second-tier diagnostic test for newborn screening.
    Luo X; Wang R; Fan Y; Gu X; Yu Y
    J Pediatr Endocrinol Metab; 2018 Aug; 31(8):927-931. PubMed ID: 30030962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.
    Baker MW; Atkins AE; Cordovado SK; Hendrix M; Earley MC; Farrell PM
    Genet Med; 2016 Mar; 18(3):231-8. PubMed ID: 25674778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-Genome Screening of Newborns? The Constitutional Boundaries of State Newborn Screening Programs.
    King JS; Smith ME
    Pediatrics; 2016 Jan; 137 Suppl 1(Suppl 1):S8-15. PubMed ID: 26729704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted exome sequencing strategy (NeoEXOME) for Chinese newborns using a pilot study with 3423 neonates.
    Cao Z; He X; Wang D; Gu M; Suo F; Qiang R; Zhang R; Song C; Wang X; Zhu B; Cao D; Yu H; Qu Y; Shen G; Wu J; Wang P; Wang J; Zhang H; Yan Z; Yu G; Zou L
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2357. PubMed ID: 38284445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods and feasibility study for exome sequencing as a universal second-tier test in newborn screening.
    Ruiz-Schultz N; Sant D; Norcross S; Dansithong W; Hart K; Asay B; Little J; Chung K; Oakeson KF; Young EL; Eilbeck K; Rohrwasser A
    Genet Med; 2021 Apr; 23(4):767-776. PubMed ID: 33442025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for lysosomal diseases: current status and potential interface with population medical genetics in Latin America.
    Giugliani R
    J Inherit Metab Dis; 2012 Sep; 35(5):871-7. PubMed ID: 22231381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.